Merck: Innovative Analytics Technologies (AT)

Merck will fund innovative projects in applied biophysical & analytical research. Challenges:

1. Analytical technologies (AT) for antibodies and antibody-drug conjugates, quantitative microbiomics, as well as technologies to determine drug target engagement, or the level of protein or nucleic acid or metabolic biomarkers.
2. AT for display materials or semiconductors (Liquid Crystals, OLED Materials, Quantum Materials, Reactive Mesogens, Photoresist Materials). E.g. Spectroscopic Methods, MS Hyphenation, Capillary Chromatography and Comprehensive Separation Technologies; Surface analytics for displays (non- or destructive), Sample preparation techniques for ultra-sensitive investigations.
3. AT for the characterization of polymers, chemical imaging, bioanalytical methods or new methods in molecular biology. Technologies of interest for example are: field flow floractionation (FFF), dynamic light scattering (DLS), chemical imaging, new chromatographic techniques, spectroscopic and spectrometric methods, electron paramagnetic resonance (EPR), microwave analytics.

Funding: Merck will enter into bilateral discussion with the top submitters to determine potential funding options. The funding period and financial support of selected projects are subject to individual negotiations.

https://www.merckgroup.com/en/research/open-innovation/350anniversaryactivities/350compoundchallenge/innovativeanalytics.html